A renal mass, or kidney mass, is an abnormal growth within the kidney, ranging from benign cysts to malignant tumors. The most common malignant kidney tumor in adults is renal cell carcinoma (RCC), with risk factors including smoking, obesity, high blood pressure, long-term dialysis, and genetic predispositions. Benign masses include simple cysts, angiomyolipomas (AMLs), and oncocytomas. In children, Wilms tumor is a primary renal malignancy linked to genetic abnormalities. Early-stage renal masses are often asymptomatic, but as the mass grows, symptoms may emerge. Diagnosis typically involves imaging and tissue analysis, with ultrasound being the initial imaging modality. A biopsy is often necessary to distinguish benign from malignant masses and determine the specific malignancy. Urine cytology and blood tests can provide supportive information. Staging, particularly for RCC, assesses the size and extent of the primary tumor, lymph node involvement, and distant metastasis.
Robotic surgery has revolutionized renal tumor removal by offering a minimally invasive approach. It uses specialized robotic arms with high-definition cameras and precise instruments, allowing for intricate tumor removal while preserving healthy kidney tissue. Small incisions minimize blood loss, reduce postoperative pain, and shorten recovery times. Robotic assistance facilitates complex procedures, particularly for challenging anatomical positions, leading to improved surgical precision and potentially reducing complications and improving long-term kidney function. While not suitable for all cases, robotic surgery is increasingly preferred for patient-centered advantages.
Mr. Lokesh Purduru from Telangana successfully underwent Robotic Surgery for Renal Tumor Removal at Yashoda Hospitals, Hyderabad, under the supervision of Dr. Aman Chandra Deshpande, Consultant Urologist, Andrologist, Kidney Transplant and Robotic Surgeon.